Established in February 2024, Alys Pharmaceuticals emerges as a pioneering force in immuno-dermatology, a venture co-founded by Medixci in collaboration with renowned dermatology and scientific experts worldwide. Formed through the integration of six asset-centric Medixci companies, Alys proudly presents a formidable pipeline of inventive programs and platforms designed to address various dermatological conditions. Guided by a...
Established in February 2024, Alys Pharmaceuticals emerges as a pioneering force in immuno-dermatology, a venture co-founded by Medixci in collaboration with renowned dermatology and scientific experts worldwide. Formed through the integration of six asset-centric Medixci companies, Alys proudly presents a formidable pipeline of inventive programs and platforms designed to address various dermatological conditions. Guided by a vision to revolutionize the treatment landscape for prevalent dermatological indications characterized by substantial unmet medical needs, Alys aims to reshape the paradigm of dermatological treatments.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.